MONOPAR THERAPEUTICS INC.

Analyst Reco. Monopar Therapeutics Inc.

Equities

MNPR

US61023L1089

Real-time Estimate Cboe BZX Other stock markets 01:21:53 2024-05-22 pm EDT			5-day change	1st Jan Change
0.623 ^USD	+1.95%		+5.17%	+84.89%

May. 09	Monopar Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 16	Monopar Therapeutics Files Provisional Patent for New MNPR-101 Construct	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

JonesTrading Upgrades Monopar Therapeutics to Buy From Hold, Price Target is $2	Apr. 11	MT
JonesTrading Downgrades Monopar Therapeutics to Hold From Buy	23-08-10	MT
HC Wainwright Adjusts Monopar Therapeutics' Price Target to $2 From $6, Keeps Buy Rating	23-05-15	MT
Maxim Group Downgrades Monopar Therapeutics to Hold From Buy	23-03-29	MT
Roth MKM Adjusts Price Target on Monopar Therapeutics to $3 From $18, Maintains Buy Rating	23-03-28	MT
EF Hutton Adjusts Price Target on Monopar Therapeutics to $17 From $24, Maintains Buy Rating	23-03-28	MT
Roth Capital Reinstates Monopar Therapeutics at Buy With $18 Price Target	22-12-09	MT
Wall Street Set to Open Lower as Mortgage Rates Climb to 16-Year High	22-10-05	MT
HC Wainwright Adjusts Monopar Therapeutics' Price Target to $6 From $9, Maintains Buy Rating	22-08-16	MT
HC Wainwright Starts Monopar Therapeutics at Buy With $9 Price Target	21-11-01	MT
MONOPAR THERAPEUTICS : Roth Capital Starts Monopar Therapeutics at Buy With $49 Price Target	21-01-28	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Rankings

More Top / Flop

Rankings

More Top / Flop

Currency / Forex

Commodities

Cryptocurrencies

Cryptocurrencies

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.

BENEFIT NOW